JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6176
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.42B
| $9K | ﹤0.01% |
465
+130
| +39% | +$2.68K |
2023 Q3
1 quarter
|
|
6177
Lifecore Biomedical
LFCR
$248M
| $8.93K | ﹤0.01% |
1,443
+57
| +4% | +$396 |
2017 Q4
24 quarters
|
|
6178
iShares iBonds Dec 2027 Term Muni Bond ETF
IBMP
$669M
| $8.88K | ﹤0.01% |
349
+3
| +0.9% | +$75 |
2023 Q1
3 quarters
|
|
6179
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.02B
| $8.83K | ﹤0.01% |
134
-77
| -36% | -$4.57K |
2022 Q3
5 quarters
|
|
6180
TH International
THCH
$42.3M
| $8.83K | ﹤0.01% |
1,009
-796
| -44% | -$6.99K |
2023 Q1
3 quarters
|
|
|
SRV
6181
NXG Cushing Midstream Energy Fund
SRV
$266M
| $8.81K | ﹤0.01% |
+260
| New | +$9.32K |
2023 Q4
0 quarters
|
|
6182
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$241M
| $8.79K | ﹤0.01% |
157
+151
| +2,517% | +$7.65K |
2022 Q3
5 quarters
|
|
|
BKSY.WS
6183
DELISTED
BlackSky Technology Inc Warrants
BKSY.WS
| – | – |
0
| – | – |
2023 Q4
0 quarters
|
|
6184
MicroSectors FANG+ Index 2X Leveraged ETNs due 8 Jan 2038
FNGO
$788M
| $8.75K | ﹤0.01% |
+190
| New | +$7.44K |
2023 Q4
0 quarters
|
|
6185
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$194M
| $8.75K | ﹤0.01% |
276
-169
| -38% | -$4.97K |
2022 Q4
4 quarters
|
|
|
OCAXW
6186
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
| – | – |
0
| – | – |
2023 Q4
0 quarters
|
|
|
ECF
6187
Ellsworth Growth & Income Fund
ECF
$160M
| $8.72K | ﹤0.01% |
1,079
-4,621
| -81% | -$35.7K |
2022 Q4
4 quarters
|
|
6188
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.57B
| $8.69K | ﹤0.01% |
209
+174
| +497% | +$6.93K |
2023 Q3
1 quarter
|
|
|
TUP
6189
DELISTED
Tupperware Brands Corporation
TUP
| $8.67K | ﹤0.01% |
4,337
+3,938
| +987% | +$7.13K |
2013 Q2
42 quarters
|
|
6190
Invesco Global Listed Private Equity ETF
PSP
$213M
| $8.64K | ﹤0.01% |
139
-1,953
| -93% | -$106K |
2023 Q2
2 quarters
|
|
6191
A2Z Smart Technologies
AZ
$248M
| $8.63K | ﹤0.01% |
2,520
| – | – |
2023 Q2
2 quarters
|
|
6192
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$150M
| $8.49K | ﹤0.01% |
344
+163
| +90% | +$3.72K |
2023 Q1
3 quarters
|
|
|
AWH
6193
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $8.46K | ﹤0.01% |
2,074
+4
| +0.2% | +$16 |
2020 Q2
14 quarters
|
|
6194
FT Vest US Equity Deep Buffer ETF June
DJUN
$358M
| $8.4K | ﹤0.01% |
221
-3,140
| -93% | -$114K |
2023 Q1
3 quarters
|
|
6195
Ebang International Holdings
EBON
$12.6M
| $8.38K | ﹤0.01% |
+548
| New | +$4.47K |
2023 Q4
0 quarters
|
|
|
SUPV
6196
Grupo Supervielle
SUPV
$597M
| $8.38K | ﹤0.01% |
+2,064
| New | +$5.63K |
2023 Q4
0 quarters
|
|
|
NAGE
6197
Niagen Bioscience
NAGE
$212M
| $8.33K | ﹤0.01% |
5,828
+4,847
| +494% | +$6.75K |
2018 Q2
22 quarters
|
|
6198
Senseonics Holdings Inc
SENS
$527M
| $8.33K | ﹤0.01% |
731
| – | – |
2017 Q4
24 quarters
|
|
|
BFX
6199
DELISTED
BowFlex Inc.
BFX
| $8.2K | ﹤0.01% |
10,650
+9,672
| +989% | +$6.59K |
2020 Q2
14 quarters
|
|
6200
Innovator US Equity Power Buffer ETF May
PMAY
$813M
| $8.18K | ﹤0.01% |
260
-46,941
| -99% | -$1.42M |
2023 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.